Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ETH Contract Participation Model for 2025 Announced by HashJ to Tap Market Opportunities
-
Cemtrex Issues Shareholder Update Highlighting Growth Across Vicon and AIS Divisions, Strategic Initiatives in Blockchain and Automation
-
Greif to Close Steel and Polymer Facility in Merced, California
-
Legend Senior Living Expands Management Team, Naming Brian Donnelly as Director of Dining Experience
-
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Travel eSIM app Saily debuts Ultra, a new premium plan for unparalleled journeys
-
Abercrombie & Fitch Co. to Report Second Quarter 2025 Results on August 27, 2025
-
NordStellar achieves SOC 2 Type II compliance, demonstrating its commitment to security
-
Viasat Comments on Letter from Carronade Capital Management
-
Orchestra BioMed Announces Pricing of $40 Million Public Offering
-
Lánasjóður sveitarfélaga - Útboð LSS 39 0303 og LSS151155
-
Bitget Surges to 7.2% Global Derivatives Market Share, Ranks Top 3 Highlights Bitcoin.com Report
-
FOXO TECHNOLOGIES INC.’S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES
-
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.08 per Share for August 2025
-
Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); Flywire Corporation (NASDAQ: FLYW); Replimune Group, Inc. (NASDAQ: REPL); and Sable Offshore Corporation (NYSE: SOC): Gra
-
Form 8.3 - [NCC GROUP PLC - 31 07 2025] - (CGAML)
-
IES Holdings Reports Fiscal 2025 Third Quarter Results
-
Artelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company’s Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of Anxiety and Depression
-
Internationally Certified MICE Training Programme Launched in the GBA, Strengthening Talent Integration Between Macao and Hengqin
-
Notice of Knight Therapeutics' Second Quarter 2025 Results Conference Call
-
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Aptose Selects Ernst & Young Global Limited as its New Independent Auditor and Calls Reconvened Meeting of its Shareholders
-
NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Nexxen Announces July 2025 Share Repurchase Program Summary
-
HTX Hot Listings Weekly Recap (July 21 - 28): SOL Memes & ETH DeFi Drive Market Surge, New Assets on HTX Post Impressive Gains
-
HTX Hot Listings Weekly Recap (July 21 - 28): SOL Memes & ETH DeFi Drive Market Surge, New Assets on HTX Post Impressive Gains
-
Verkkokauppa.com Oyj - Managers' Transactions – Samuli Seppälä
-
Yachting: Monaco Triumphs at the Admiral’s Cup, Historic Victory for the Yacht Club
-
TransAlta Reports Strong Second Quarter 2025 Results, Advancement of Strategic Priorities and Reaffirms Guidance
-
BioXcel Therapeutics Announces Last Patient Last Visit in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
-
NANO Nuclear Selected for Inclusion in the Solactive Global Uranium & Nuclear Components Total Return Index, Qualifying It for Inclusion in the Prominent Global X Uranium ETF (“URA”)
-
NANO Nuclear Selected for Inclusion in the Solactive Global Uranium & Nuclear Components Total Return Index, Qualifying It for Inclusion in the Prominent Global X Uranium ETF (“URA”)
-
Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights
-
PyroGenesis Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
-
OTC Markets Group Welcomes Talga Group Ltd. to OTCQX
-
OTC Markets Group Welcomes Apex Critical Metals Corp. to OTCQX
-
Perella Weinberg Reports Second Quarter 2025 Results; Adds Private Funds Advisory Platform with Acquisition of Devon Park Advisors
-
Brookfield Renewable Announces Strong Second Quarter Results
-
ProVen VCT plc: Total voting rights
-
ProVen Growth and Income VCT plc: Total voting rights
-
ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET
-
Brookfield Business Partners Reports Second Quarter 2025 Results
-
Descartes Sets Date to Announce Second Quarter Fiscal 2026 Financial Results
-
LYNO AI Launches 2025 Presale: Advanced Cross-Chain Arbitrage Protocol Enters Early Bird Phase
-
Bosch wants to grow significantly faster than the market in the heating, ventilation, and cooling sector
-
Regeneron Reports Second Quarter 2025 Financial and Operating Results
-
LyondellBasell reports second quarter 2025 earnings
-
CNH Industrial N.V. Reports Second Quarter 2025 Results
-
On Triple SARM Product Launch: GW-501516, RAD-140, and MK-677 Now Available for Research Use Only
